Molecular subtypes of breast cancers are categorized based on the receptors they overexpress: Estrogen receptor (ER+), progesterone receptor (PR+), and EGFR receptor Her2 (HER2+) amplification. This evidence concerns the gene ERBB2 and breast cancer.